“Success stories and challenges in OneHealth drug discovery for VBPD”
May 18, 2026, from 10:00 to 13:00 CET
This workshop will provide a state-of-the-art overview and help define a collaborative, multidisciplinary roadmap within COST Action CA21111 across all career stages.
This workshop will bring together senior and early-career members to highlight success stories and challenges in One Health drug discovery strategies for vector-borne parasitic diseases, encountered in both scientific and communication activities across the network.
Registration link: Here is the Google Form link to register: https://docs.google.com/forms/d/e/1FAIpQLScph1TMmdneLVG40cDjG04NPDGWbknM2eKL2njg-ajyA8l7Bg/viewform?usp=header
May 18, 2026, from 10:00 to 13:00 CET
10:00 – 10:15 Welcome and introduction
10:15 – 10:35 Prof. Anabela Cordeiro Silva- I3S and Faculty of Pharmacy, University of Porto
Blended Intensive Program (BIP) on Drug Resistance in Cancer and Infectious Diseases
10:35 – 10:55 Dr Clara Lima - I3S and Faculty of Pharmacy, University of Porto
10:55 – 11:15: Dr. Gulsah Bayraktar - Department of Pharmaceutical Chemistry, Ege University, Turkey
Development of Novel Thiazolopyrimidine Derivatives Active Against Visceral and Cutaneous Leishmania
11:15 – 11:35 Dr. Elisa Uliassi - Department of Pharmacy and Biotechnology, University of Bologna
My Journey in the OneHealthDrugs COST Action: Personal Experiences and Perspectives
10’ BREAK
11:45 – 12:05: Dr Daniele Aiello - Department of Life Sciences, University of Modena and Reggio Emilia
Computational Investigation of Xanthine-Based Inhibitors Targeting Trypanosomatid Pteridine Reductase 1
12:05 – 12.20: Aurora Gaza - - Department of Pharmacy and Biotechnology, University of Bologna (STSM at the School of Infection and Immunity, University of Glasgow)
Biological evaluation of small-molecule hydrophobic degraders for antiparasitic drug discovery and chemical biology applications
12:20 – 12.35: Dr Bianca Martinengo- - Department of Pharmacy and Biotechnology, University of Bologna
Unlocking Biocatalytic Oxidative Systems for the Sustainable Synthesis of Pharmaceuticals from Food Waste
12:40 Open discussion and reflections
Conclusions and way forward
COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. The COST ACTIONS help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.
One Health drugs against parasitic vector borne diseases in Europe and beyond
OneHealthdrugs
24/10/2022
23/10/2026
27/05/2022
Download file
Maria Paola Costi
Anabela Cordeiro da Silva
Maria Cristina Notarsanto
Maria Esposito and Laura Leonardi